WASHINGTON, April 3 (TNSFR) -- The U.S. Department of Commerce Foreign-Trade Zones (FTZ) Board has announced that AstraZeneca Pharmaceuticals LP has submitted a notification for proposed production activity at its facilities in Mount Vernon, Indiana, within Subzone 177A. The notification, officially received on March 27, 2025, conforms to the FTZ Board's regulatory requirements and outlines specific foreign-status materials and finished products that AstraZeneca seeks to produce under FTZ p . . .

Click here for more information about our products